Submit Press Release GroupWeb News Network Africa Alabama Alaska Arizona Arkansas Asia California China Colorada Connecticut Washington DC Delaware Florida France Georgia Germany Ghana Hawaii Idaho Illinois India Indiana Iowa Italy Japan Kansas Kentucky Korea Lousiana Main MaryLand Massachusetts Michigan Minnesota Mississippi Misouri Motana Nebraska Nevad New Hampshire New Jersey New Mexico New York Nigeria North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island Rhode Island Russia South Africa South Carolina South Dakota Spain Tennessee Texas UK Utah Vermont Virginia Washington Weather West Virginia Wisconsin

Home | Search Global IT News: IT News & Press Release Distribution: Bioburden Testing in Raw Material & In-process Application   (IT-NEWSWIRE.COM, July 10, 2018 ) The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, at a CAGR of 9.8% from 2014 to 2019. Major factors driving the growth of this market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost this market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards which lengthen the approval process in some countries may hinder the growth of this market. Emerging economies such as India and China present an array of opportunities for this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=17983056 North America dominated the microbial limit testing market, with the U.S. accounting for a major market share in 2014. However, Asia is poised to grow at the highest CAGR during the forecast period. Growth in the Asian market will be driven by factors such as strong investments and rapid growth in the pharmaceutical and biotechnology industries, growing medical device industry, government initiatives and rising awareness for bioburden testing in various Asian countries. Prominent players in the bioburden testing market are Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co., Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.). Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=17983056 MarketsandMarkets Mr. Shelly Singh 1-888-600-6441 sales@marketsandmarkets.com Source: EmailWire.Com Source: EmailWire.com

Information Technology Resources Application Software Bioinformatics Computers Computer Games Enterprise Software Graphics/Printing/CAD Hardware/Peripheral industrial Computers Information Internet Multimedia Networking Public Sector Robotics Semiconductor Software Telecommunications Webmaster Information Technology (IT) Advertisement Information Technology Sponsors Information Technology Publications We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including: The Integration Journey—a Field Guide to Enterprise Integration for SOA Government Technology\'s Public CIO Protecting Content During Business Disruption: Are You Covered? No credit cards, coupons, or promo codes required. Try it today!